Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7345081 Azabicyclo-octane inhibitors of IAP

Patent 7345081 was granted and assigned to Genentech on March, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 18, 2008

Patent Application Number

11088008

Date Filed

March 22, 2005

Patent Citations Received

US Patent 11857519 Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

0

US Patent 11986531 Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides

0

US Patent 11957759 Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

0

US Patent 11707452 Modulators of alpha-synuclein proteolysis and associated methods of use

0

US Patent 11912699 Tau-protein targeting compounds and associated

0

Patent Primary Examiner

Golam M. M. Shameem

Patent abstract

The invention provides novel inhibitors of IAP that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7345081 Azabicyclo-octane inhibitors of IAP

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.